India, Nov. 4 -- Viridian Therapeutics, Inc. (VRDN) is up 5.49 percent, gaining $1.38 to $26.53 on Wednesday. The company's third-quarter results showed its net loss widening to $101.2 million, compared with $34.6 million a year earlier.
Net loss per share increased to $0.81 from $0.34. However, total revenue declined to $25.75 million from $70.57 million, primarily reflecting lower license revenue, while the company recorded $24.67 million in product revenue.
The stock is currently trading at $26.53, compared with the previous close of $25.15 on the Nasdaq. It opened at $28.26 and recorded a day's range of $25.07 to $29.74. Trading volume stands at approximately 3.14 million shares, above the average volume of 1.87 million shares.
googl...